FDA greenlights Quest, LetsGetChecked home-based coronavirus tests
The FDA is looking to add more tests to its list of authorized, home-based coronavirus diagnostics following its recent green lights for lab testing giant...
Continue ReadingOver 50 Covid-19 candidates under clinical trials in India
Over 50 clinical trials for a Covid-19 vaccine have started in India as researchers globally look for ways to stop the ravaging pandemic. Data from...
Continue ReadingIndia invites Japanese firms to invest in its pharma and medical devices industry
A webinar on ‘Medical Devices and API sector: Challenges & Emerging Opportunities’ was held on May 22, 2020, for business and trade collaboration between India...
Continue ReadingHuman trials of British coronavirus vaccine to reach 10,000
Oxford University and AstraZeneca (AZN.L) are recruiting around 10,000 adults and children in Britain for trials of an experimental coronavirus vaccine, a day after receiving...
Continue ReadingNew COVID-19 test developed in Singapore detects past infection within an hour
A new COVID-19 test that can rapidly assess if a person has been previously infected with the coronavirus is now available to hospitals in Singapore....
Continue ReadingCarlyle and former Mylan top executive in talks to buy Ra Chem Pharma from Micro Labs
The Carlyle-Hari Babu consortium is in advanced stages of negotiations to buy out Hyderabad-based API ( active pharmaceutical ingredients) maker Ra Chem Pharma from majority...
Continue ReadingBGU researcher develops one-minute COVID-19 breath test
Ben-Gurion University of the Negev’s Prof. Gabby Sarusi has developed and is now validating a test that identifies carriers of the COVID-19 virus in less...
Continue ReadingThe race for coronavirus vaccines: a graphical guide
More than 90 vaccines are being developed against SARS-CoV-2 by research teams in companies and universities across the world. Researchers are trialling different technologies, some...
Continue ReadingJubilant Life Sciences Enters Into Licensing Agreement With Gilead For Remdesivir, Potential Therapy For Covid-19
Jubilant Life Sciences Limited has announced that its subsidiary, Jubilant Generics Limited, has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. that will...
Continue Reading